Article Details

Analysts Anticipate BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Announce -$0.23 EPS

Retrieved on: 2020-11-05 07:20:41

Tags for this article:

Click the tags to see associated articles and topics

Analysts Anticipate BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Announce -$0.23 EPS. View article details on hiswai:

Excerpt

<b>Schonfeld Strategic Advisors</b> LLC now owns 241,411 shares of the biotechnology company's stock valued at $830,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo